TheraVida Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:TheraVida Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10559
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
TheraVida Inc (TheraVida) is a clinical stage specialty pharmaceutical company focused on the development of new therapies for the treatment of primary focal hyperhidrosis. The company’s lead candidate THVD-102 is an oral acting drug used for the treatment of primary and secondary focal hyperhidrosis. It develops a proprietary and patent-protected drug delivery platform to reduce or eliminate problematic drug side effects for patients. TheraVida tests patent-protected combination drug technology in multiple human clinical trials. The company develops its products using patent-protected combination drug technology. TheraVida is headquartered in San Mateo, California, the US.

TheraVida Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraVida Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
TheraVida Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TheraVida Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
TheraVida Raises Additional US$5.3 Million In Venture Financing 10
Licensing Agreements 11
Dermavant Sciences Enters into Licensing Agreement with TheraVida 11
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 12
TheraVida Inc – Key Competitors 13
TheraVida Inc – Key Employees 14
TheraVida Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
TheraVida Inc, Pharmaceuticals & Healthcare, Key Facts 2
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraVida Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraVida Inc, Deals By Therapy Area, 2012 to YTD 2018 8
TheraVida Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
TheraVida Raises Additional US$5.3 Million In Venture Financing 10
Dermavant Sciences Enters into Licensing Agreement with TheraVida 11
TheraVida Enters Into Licensing Agreement With SK Chemicals For THVD-201 And THVD-202 12
TheraVida Inc, Key Competitors 13
TheraVida Inc, Key Employees 14

List of Figures
TheraVida Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
TheraVida Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
TheraVida Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[TheraVida Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • STRATA Skin Sciences Inc (SSKN):企業の財務・戦略的SWOT分析
    STRATA Skin Sciences Inc (SSKN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Lietuvos energijos gamyba AB (LNR1L):電力:M&Aディール及び事業提携情報
    Summary Lietuvos energijos gamyba AB (Lietuvos), a subsidiary of Lietuvos Energija UAB, is a state-controlled electric utility that generates, imports and exports, and supplies electricity and thermal energy. It generates electricity from hydro, thermal and renewable energy sources. The company trad …
  • Netcare Limited:企業の戦略・SWOT・財務情報
    Netcare Limited - Strategy, SWOT and Corporate Finance Report Summary Netcare Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Proton Holdings Berhad:企業の戦略的SWOT分析
    Proton Holdings Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Calumet Specialty Products Partners, L.P.:企業の戦略・SWOT・財務情報
    Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Calumet Specialty Products Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Aditya Birla Retail Ltd:企業の戦略的SWOT分析
    Aditya Birla Retail Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Torishima Pump Mfg Co Ltd (6363):企業の財務・戦略的SWOT分析
    Torishima Pump Mfg Co Ltd (6363) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Clovis Oncology Inc (CLVS):製薬・医療:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Gran Tierra Energy Inc (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • Petrolympic Ltd (PCQ):企業の財務・戦略的SWOT分析
    Summary Petrolympic Ltd (Petrolympic) is an oil and gas exploration and development company that acquires, explores and develops light crude oil and natural gas in North America. The company holds interests in conventional natural gas and light oil projects in Gaspe Peninsula of Quebec. It holds int …
  • Tandem Diabetes Care Inc (TNDM)-医療機器分野:企業M&A・提携分析
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company offers products which include t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect appl …
  • Icade SA:企業のM&A・事業提携・投資動向
    Icade SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Icade SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • LiNiu Technology Group:企業の戦略・SWOT・財務分析
    LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report Summary LiNiu Technology Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • GraceKennedy Ltd (GK):企業の財務・戦略的SWOT分析
    GraceKennedy Ltd (GK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …
  • PT Bumi Resources Tbk:企業のM&A・事業提携・投資動向
    PT Bumi Resources Tbk - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PT Bumi Resources Tbk Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Topas Therapeutics GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Topas Therapeutics GmbH (Topas Therapeutics) is a biotechnological company that designs and develops nanoparticle products loaded with antigenic peptides. The company’s pre-clinical pipeline categories are used in the treatment of allergies, immune mediated diseases, autoimmune diseases, and …
  • Unipack, Inc.:企業の戦略・SWOT・財務分析
    Unipack, Inc. - Strategy, SWOT and Corporate Finance Report Summary Unipack, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Integra Holdings Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Integra Holdings Ltd (Integra Holdings), a subsidiary of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, is a healthcare investment company that invests in biopharmaceutical companies with products in clinical and pre-clinical stages of development. The company …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆